Outcomes of Transcatheter and Surgical Aortic Valve Replacement in High-Risk Patients With Aortic Stenosis and Left Ventricular Dysfunction
Author(s) -
Sammy Elmariah,
Igor F. Palacios,
Thomas McAndrew,
Irene Hueter,
Ignacio Inglessis,
Joshua N. Baker,
Susheel Kodali,
Martin B. Leon,
Lars G. Svensson,
Philippe Pîbarot,
Pamela S. Douglas,
William F. Fearon,
Ajay J. Kirtane,
Hersh S. Maniar,
Jonathan Passeri
Publication year - 2013
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.113.000650
Subject(s) - medicine , ejection fraction , cardiology , odds ratio , valve replacement , aortic valve replacement , stenosis , confidence interval , aortic valve stenosis , aortic valve , heart failure
The Placement of Aortic Transcatheter Valves (PARTNER) trial demonstrated similar survival after transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively) in high-risk patients with symptomatic, severe aortic stenosis. The aim of this study was to evaluate the effect of left ventricular (LV) dysfunction on clinical outcomes after TAVR and SAVR and the impact of aortic valve replacement technique on LV function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom